Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,58%
1.085,23
-6,28
-0,58%
—1.091,511.090,401.090,401.081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,25%
608,61
-1,50
-0,25%
—610,11610,11610,11606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,29%
1.241,54
+3,56
+0,29%
—1.237,981.237,831.241,621.225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,13%
1.742,39
-2,32
-0,13%
—1.744,711.740,951.746,201.735,64——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
642,27
+2,09
+0,33%
—640,18639,92642,85636,70——
SIXR
Staples
SIXR
Staples
SIXR
+0,07%
850,21
+0,63
+0,07%
—849,58845,27850,97841,28——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,10%
217,70
+0,22
+0,10%
—217,48217,48217,77216,39——
SIXT
Technology
SIXT
Technology
SIXT
+0,67%
3.282,46
+21,77
+0,67%
—3.260,693.273,363.287,813.269,07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,34%
945,69
+3,24
+0,34%
—942,45939,39948,80934,04——
SIXV
Health care
SIXV
Health care
SIXV
-0,11%
1.465,20
-1,60
-0,11%
—1.466,801.464,701.466,471.458,68——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,10%
2.399,90
+2,40
+0,10%
—2.397,502.395,032.404,632.391,98——
4568:TYO
Daiichi Sankyo Co Ltd
2.616,50 JP¥
+1,08%
(+28,00) 1D
1 may, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4568...
Açın
2.597 JP¥
High
2.650 JP¥
Low
2.568 JP¥
Mkt. cap
4,96 trln
Avg. vol.
8,66 mln
Volume
7,94 mln
Dividend
2,64%
Quarterly dividend
17 JP¥
P/E ratio
15,99
52-wk high
4.178 JP¥
52-wk low
2.463 JP¥
EPS
164 JP¥
Shares outstanding
647,77 mln
No. of employees
20K
News stories
From sources across the web
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees19,8K
Founded28 sen 2005
HeadquartersChuo City, Tokio, Yaponiya
Sector-
Websitedaiichisankyo.co.jp
Next call 7 gün ərzində
11 may, B.e., 05:00
Fiscal Period
Q4 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
-/ (588,52 mlrd est.)JPY
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
518,69 mlrd
474,60 mlrd
500,76 mlrd
558,11 mlrd
Cost of goods sold
94,34 mlrd
92,35 mlrd
155,98 mlrd
118,28 mlrd
Cost of revenue
94,34 mlrd
92,35 mlrd
155,98 mlrd
118,28 mlrd
Research and development expenses
133,32 mlrd
105,95 mlrd
111,72 mlrd
122,11 mlrd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
208,21 mlrd
180,35 mlrd
189,08 mlrd
228,23 mlrd
Operating expense
360,74 mlrd
285,54 mlrd
297,25 mlrd
350,29 mlrd
Total operating expenses
455,08 mlrd
377,88 mlrd
453,23 mlrd
468,57 mlrd
Operating income
63,61 mlrd
96,71 mlrd
47,52 mlrd
89,54 mlrd
Other non operating income
6,04 mlrd
-1,00 mln
-
-
EBT including unusual items
80,63 mlrd
105,44 mlrd
57,78 mlrd
106,73 mlrd
EBT excluding unusual items
65,04 mlrd
105,44 mlrd
57,78 mlrd
106,73 mlrd
Income tax expense
-6,52 mlrd
19,94 mlrd
12,46 mlrd
20,10 mlrd
Effective tax rate
-8,09%
18,91%
21,57%
18,83%
Other operating expenses
19,21 mlrd
-760,00 mln
-3,56 mlrd
-49,00 mln
Net income
87,15 mlrd
85,50 mlrd
45,31 mlrd
86,63 mlrd
Net profit margin
16,80%
18,02%
9,05%
15,52%
Earnings per share
-
-
-
-
Interest and investment income
2,65 mlrd
9,78 mlrd
10,68 mlrd
19,08 mlrd
Interest expense
-4,45 mlrd
-1,42 mlrd
-834,00 mln
-2,16 mlrd
Net interest expenses
-1,80 mlrd
8,36 mlrd
9,84 mlrd
16,91 mlrd
Depreciation and amortization charges
-
-
-
-
EBITDA
81,59 mlrd
114,51 mlrd
66,41 mlrd
109,18 mlrd
Gain or loss from assets sale
3,85 mlrd
199,00 mln
1,75 mlrd
573,00 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer